pharmaceuticals
pharmaceuticals Articles
Shares of FibroGen saw a handy gain on Wednesday after the biopharmaceutical company announced the pricing of its underwritten follow-on offering.
Published:
Shanghai-based biopharmaceutical company Zai Lab has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Zynerba Pharmaceuticals saw its shares sink to a 52-week low after the firm announced results from its midstage trial evaluating cannabidiol gel for the treatment of knee pain due to osteoarthritis.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
One in 12 U.S. doctors received more than $46 million from 2013 to 2015 in payments from drug companies that were selling strong painkillers, according to a new study.
Published:
Last Updated:
Acadia Pharmaceuticals reported its second-quarter financial results after the markets closed on Tuesday.
Published:
Last Updated:
Mylan released its most recent quarterly earnings report before the markets opened on Wednesday. Unfortunately, the earnings and guidance weren't strong enough to hold up the firm and as a result...
Published:
Last Updated:
Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
Published:
Last Updated:
A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its approval of Imbruvica for the treatment of adult patients with chronic graft versus host disease.
Published:
Last Updated:
Clementia Pharmaceuticals entered the market with a bang, with shares priced above expected price range.
Published:
Last Updated:
Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming up short on revenues.
Published:
Last Updated:
No wonder there is a national problem with opioid use. A contributing factor has to be that almost 92 Americans used opioids in 2015.
Published:
Last Updated:
Tetraphase Pharmaceuticals saw its shares pull back on Friday after the company announced that it has priced a secondary offering.
Published:
Last Updated:
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated: